HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Caon, C. Articles by Khan, O.A. Search for Related Content PubMed PubMed Citation Articles by Caon, C. Articles by Khan, O.A.

Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis

From the Multiple Sclerosis Center, Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan.

Address correspondence and reprint requests to Dr. Omar A. Khan, Department of Neurology, Wayne State University School of Medicine, 4201 St. Antoine, 8D-University Health Center, Detroit, MI 48201.

Intercaudate nucleus ratio (ICR) is a linear measure of brain atrophy that does not require software application and is independent of image acquisition techniques. The authors examined the relationship between ICR and disability in 190 patients with MS. The results show that ICR correlates with Expanded Disability Status Scale score (r = 0.67; p = 0.0001) and disease duration (r = 0.32; p < 0.01). Intercaudate ratio appears to be a reliable and reproducible linear measure of brain atrophy and correlates with disability and disease duration in MS.

This article has been cited by other articles:

				R. P. Lisak Neurodegeneration in multiple sclerosis: Defining the problem Neurology, May 29, 2007; 68(22_suppl_3): S5 - S12. [Abstract] [Full Text] [PDF]